Vicki Moore, PhD

Researchers sought to determine the relationship between individual items and total score on the Lee Fatigue Scale and morning fatigue after chemotherapy.

A phase 2 study sought to determine the effectiveness and safety of psilocybin for the reduction of depression severity in patients with cancer.

In a phase 2 trial, pembrolizumab produced an overall response rate of 89% in patients with unresectable desmoplastic melanoma.

A report described a series of 3 patient cases that demonstrated potential benefit of immunotherapy followed by antiangiogenic therapy and chemotherapy.

Researchers sought to determine the effectiveness of using a Smartphone app to conduct postoperative follow-up and patient satisfaction with the method.

Adding pegargiminase to standard frontline chemotherapy improves outcomes in patients with nonepithelioid pleural mesothelioma, a phase 2/3 study suggests.

Researchers sought to determine physician preferences for treating patients with relapsed/refractory diffuse large B-cell lymphoma in the third line setting.

Researchers sought to determine the role of certain genetic variants as biomarkers in primary central nervous system lymphoma.

More than 20% of US patients diagnosed with cancer during pregnancy may be unable to terminate that pregnancy due to abortion laws in their state, a new study suggests.

Niraparib maintenance does not improve overall survival in patients with platinum-sensitive recurrent ovarian cancer, updated data suggest.